HomeCOPN • SWX
add
Cosmo Pharmaceuticals NV
Previous close
CHF 90.30
Day range
CHF 86.00 - CHF 89.70
Year range
CHF 41.60 - CHF 129.40
Market cap
1.52B CHF
Avg Volume
74.22K
P/E ratio
-
Dividend yield
2.18%
Primary exchange
SWX
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 26.23M | -59.82% |
Operating expense | 14.97M | -22.87% |
Net income | -801.00K | -102.58% |
Net profit margin | -3.05 | -106.42% |
Earnings per share | — | — |
EBITDA | 104.50K | -99.72% |
Effective tax rate | -488.71% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 122.76M | -14.13% |
Total assets | 612.64M | -5.28% |
Total liabilities | 123.46M | -12.86% |
Total equity | 489.18M | — |
Shares outstanding | 16.19M | — |
Price to book | 3.03 | — |
Return on assets | -1.13% | — |
Return on capital | -1.40% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -801.00K | -102.58% |
Cash from operations | -6.69M | -118.43% |
Cash from investing | 4.25M | 117.42% |
Cash from financing | 4.87M | 127.97% |
Net change in cash | 2.56M | 149.86% |
Free cash flow | 1.08M | -95.44% |
About
Founded
1997
Website
Employees
325
